The Department of Pharmaceuticals (DoP) has prepared the Uniform Code of Pharmaceuticals Marketing Practices (UCPMP) and its voluntarily adoption and compilation was started from January 1 this year.
The code also prohibits companies from supplying drugs as samples, which are used to treat depression, inducing sleep such as hypnotic, sedative or tranquilliser.
As per the code, the companies should not offer any gift or benefits in kind or offer foreign trips to doctors and if any firm was found following such practices, it could be expelled from the association.
“As of now it is voluntary for pharma companies to follow UCPMP, but we are considering to make it compulsory in next few months,” a senior government official said.
A process has already been started to rework the entire code so that it could be made compulsory and the department will hold discussions for the same with all stakeholders including industry, Medical Council of India and others, the official added.
Discussions will also take place with Drug Controller General (India), Ministry of Health and Family Welfare and NGOs, the official said.
The marketing code which also cover medical devices sector was initially implemented from January 1 this year for a period of six months, which was extended for two months till August 31 and now has been extended for four months till December 31 this year.
As per the code, companies can extend funding for medical research and study through approved institutions as per law and it should be fully disclosed. The code also have stringent measures for audio video promotional activities and for the supply of free samples of medicines.
